yahoo_financeOriginal article
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
RegulatoryPrimeCPositive
AI Analysis
Summary
NeuroSense has completed the pre-NDS (New Drug Submission) process for PrimeC and is on track to file with Health Canada in December 2026.
Outcome Details
Completed pre-NDS process and advancing toward filing
Importance:5/10
Sentiment:
0.60
regulatory progressHealth CanadaNDS filingNeuroSense
Read the original article
Published by yahoo_finance on August 6, 2026 3:29 PM